Organoclick AB (ORGC) — Capital Reinvestment Ratio
Latest as of December 2025:
0.02x
Organoclick AB (ORGC) has a Capital Reinvestment Ratio of 0.02x as of December 2025, meaning it reinvests 0% of its operating cash flow (Skr2.97 Million) in capital expenditures (Skr51.00K). See ORGC cash flow after capex ratio to measure how efficiently the company converts operating cash flow to free cash.
Capital Reinvestment Ratio
0.02x
Capex / Operating Cash Flow
Operating Cash Flow
Skr2.97 Million
SEK
Capital Expenditures
Skr51.00K
SEK
Data as of
Dec 2025
Most recent filing
Organoclick AB Capital Reinvestment Ratio (2013–2024)
This chart tracks Organoclick AB's Capital Reinvestment Ratio across 4 annual periods.
Annual Capital Reinvestment Ratio for Organoclick AB (2013–2024)
Year-by-year Capital Reinvestment Ratio for Organoclick AB from 2013 to 2024. For live market cap and broader valuation context, see Organoclick AB market capitalisation.
| Year | Reinvestment Ratio | Operating CF (SEK) | Capital Expenditures | YoY Change |
|---|---|---|---|---|
| 2024 | 2.53x | Skr3.60 Million | Skr9.11 Million | ▼ -84.3% |
| 2023 | 16.15x | Skr533.00K | Skr8.61 Million | ▲ +355.6% |
| 2020 | 3.55x | Skr5.47 Million | Skr19.40 Million | ▲ +1.4% |
| 2013 | 3.50x | Skr313.54K | Skr1.10 Million | — |
Capital Reinvestment Ratio = ABS(Capital Expenditures) / Operating Cash Flow